PharmacyCodes



Furabid en es it fr

Categorie

Furabid Les marques, Furabid Analogs

Furabid Les marques melange

  • No information avaliable

    • Furabid Formule chimique

    C8H6N4O5

    Furabid RX lien

    http://www.rxlist.com/cgi/generic/nitro25m.htm

    Furabid FDA fiche

    Furabid msds (fiche de securite des materiaux)

    Furabid MSDS

    Furabid Synthese de reference

    Aucune information disponible

    Furabid Poids moleculaire

    238.157 g/mol

    Furabid Point de fusion

    263 oC

    Furabid H2O Solubilite

    79,5 mg / L

    Furabid Etat

    Solid

    Furabid LogP

    -0.04

    Furabid Formes pharmaceutiques

    Tablet

    Furabid Indication

    Pour le traitement de l'infection des voies urinaires

    Furabid Pharmacologie

    Nitrofurantoin, un nitrofurane agent antibactérien, est disponible sous forme microcristalline et macrocristallin pour traiter les infections des voies urinaires causées par de nombreuses bactéries gram-négatives et certaines bactéries Gram-positives.

    Furabid Absorption

    Aucune information disponible

    Furabid Toxicite

    Aucune information disponible

    Furabid Information pour les patients

    Patients should be advised to take Macrobid with food (ideally breakfast and dinner) to further enhance tolerance and improve drug absorption. Patients should be instructed to complete the full course of therapy; however, they should be advised to contact their physician if any unusual symptoms occur during therapy.

    Patients should be advised not to use antacid preparations containing magnesium trisilicate while taking Macrobid.

    Patients should be counseled that antibacterial drugs including Macrobid should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Macrobid is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Macrobid or other antibacterial drugs in the future.

    Furabid Organismes affectes

    Gram négatif et certaines bactéries Gram positives